• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,636
2,054
2,048
1,709
1,515

COUNTRY

998
814
243
235
194

CATEGORIES

  • 858
  • 185
  • 123
  • 317
  • 459
  • 230
  • 258
  • 65
  • 76
  • 792
  • 1,404
  • 855
  • 24
  • 410
  • 1,285
  • 2,264
  • 25
  • 269
  • 0
  • 49

PRICE

5,042
10,480
19,529
25,593

PUBLISHED

106
5,018
9,400
25,593

PRODUCT TYPE

21,548
1,950
957
877
164
37
21
21
11
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Adult Malignant Glioma Global Clinical Trials Review, H1, 2014

Adult Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Adult Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Adult Malignant...

February 2014
FROM
Investigation Report on China Bevacizumab Market, 2009-2018 Investigation Report on China Bevacizumab Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Bevacizumab Market, 2009-2018

Bevacizumab is an important kind of remedy for metastatic colon cancer, which belongs to humanized anti-VEGF monoclonal antibody Approved by FDA, bevacizumab came into the market in 2004, with the brand...

February 2014
FROM
Investigation Report on China Insulin Glargine Market, 2009-2018 Investigation Report on China Insulin Glargine Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Insulin Glargine Market, 2009-2018

With the improvement of people's living standard and changing of lifestyles, as well as deepening of the aging of society, prevalence rate of diabetes keeps rising, making it the third most threatening...

February 2014
FROM

Taiwan Pharmaceuticals and Healthcare Report Q2 2014

BMI View: On the back of the rising aged dependency ratio, demands for long-term care and welfare expenditure are expected to rise in Taiwan, adding further weight on the government's fiscal burden....

February 2014

AIDS - Related Kaposi's Sarcoma Global Clinical Trials Review, H1, 2014

AIDS - Related Kaposi's Sarcoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “AIDS - Related Kaposi's Sarcoma Global Clinical Trials Review, H1, 2014" provides data on...

February 2014
FROM

Lip Cancer Global Clinical Trials Review, H1, 2014

Lip Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Lip Cancer Global Clinical Trials Review, H1, 2014" provides data on the Lip Cancer clinical trial scenario....

February 2014
FROM
Investigation Report on China Telmisartan Market, 2009-2018 Investigation Report on China Telmisartan Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Telmisartan Market, 2009-2018

According to statistics from WHO, one-third of the world's adults have high blood pressure Death toll of this disease equals to half of the total number caused by stroke and heart attack Angiotensin...

February 2014
FROM

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the AIDS - Related...

February 2014
FROM

AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H1, 2014

AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H1, 2014" provides...

February 2014
FROM
Advances in Immunology, Vol 121 Advances in Immunology, Vol 121 - Product Thumbnail Image

Advances in Immunology, Vol 121

Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that...

February 2014
Investigation Report on China Duloxetine Market, 2009-2018 Investigation Report on China Duloxetine Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Duloxetine Market, 2009-2018

Depression is a common mood disorder that belongs to high-incidence mental diseases worldwide Its main clinical features are a state of low mood and aversion to activity, and sometimes even suicidal...

February 2014
FROM
Investigation Report on China Montelukast Market, 2009-2018 Investigation Report on China Montelukast Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Montelukast Market, 2009-2018

There are over 30 million people suffering from seasonal asthma of different levels worldwide, and the situation is worse in deeply contaminated countries and regions with high tobacco consumption Asthma...

February 2014
FROM
Investigation Report on China Budesonide Market, 2009-2018 Investigation Report on China Budesonide Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Budesonide Market, 2009-2018

Asthma and allergic rhinitis are both very common diseases in the world today As the global atmosphere becomes more and more seriously contaminated, incidence of these diseases increases year by year...

February 2014
FROM
Investigation Report on China Budesonide Market, 2009-2018 Investigation Report on China Budesonide Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Budesonide Market, 2009-2018

Asthma and allergic rhinitis are both very common diseases in the world today As the global atmosphere becomes more and more seriously contaminated, incidence of these diseases increases year by year...

February 2014
FROM
Investigation Report on China Montelukast Market, 2009-2018 Investigation Report on China Montelukast Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Montelukast Market, 2009-2018

There are over 30 million people suffering from seasonal asthma of different levels worldwide, and the situation is worse in deeply contaminated countries and regions with high tobacco consumption Asthma...

February 2014
FROM
Investigation Report on China Duloxetine Market, 2009-2018 Investigation Report on China Duloxetine Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Duloxetine Market, 2009-2018

Depression is a common mood disorder that belongs to high-incidence mental diseases worldwide Its main clinical features are a state of low mood and aversion to activity, and sometimes even suicidal...

February 2014
FROM
Therapeutic Class Overview : Psoriasis – Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change Future Treatment Paradigm Therapeutic Class Overview : Psoriasis – Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change Future Treatment Paradigm - Product Thumbnail Image Special Offer Sale Banner

Therapeutic Class Overview : Psoriasis – Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change Future Treatment Paradigm

Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded considerably and improved patients' pain, function, and quality of life Approved biologics...

February 2014
FROM
Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical Companies Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical Companies - Product Thumbnail Image Special Offer Sale Banner

Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical Companies

There are more than 1400 sustained or controlled release drugs have been approved all over the world Revenues within the global generics market reached an estimated value of $265 b in 2012, showing...

February 2014
FROM
Therapeutic Class Overview: Treating Refractory Hematological Malignancies Therapeutic Class Overview: Treating Refractory Hematological Malignancies - Product Thumbnail Image Special Offer Sale Banner

Therapeutic Class Overview: Treating Refractory Hematological Malignancies

Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes Over the past decade, Proteasome inhibitor,...

February 2014
FROM

Oman Pharmaceuticals and Healthcare Report Q2 2014

BMI View: This quarter has seen a focus on development and opening of government-funded and private healthcare infrastructure projects aimed at meeting growing domestic demand for healthcare services...

February 2014
Loading Indicator

Our Clients

Our clients' logos